Investment Analysts’ updated eps estimates for Monday, March 23rd:
Ahold (OTCMKTS:ADRNY) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
Ambarella (NASDAQ:AMBA) had its buy rating reiterated by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $115.00 price target on the stock.
Amazon.com (NASDAQ:AMZN) had its buy rating reaffirmed by analysts at TD Cowen. TD Cowen currently has a $300.00 target price on the stock.
Apogee Therapeutics (NASDAQ:APGE) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $137.00 target price on the stock.
AvePoint (NASDAQ:AVPT) had its market perform rating reaffirmed by analysts at William Blair.
Anavex Life Sciences (NASDAQ:AVXL) had its buy rating reiterated by analysts at D. Boral Capital. The firm currently has a $24.00 target price on the stock.
Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF) had its hold rating reaffirmed by analysts at Berenberg Bank.
Brookfield Renewable (NYSE:BEPC) had its underweight rating reissued by analysts at Morgan Stanley. They currently have a $42.00 target price on the stock.
Brookfield Infrastructure (NYSE:BIPC) had its underweight rating reissued by analysts at Morgan Stanley. They currently have a $45.00 target price on the stock.
Backblaze (NASDAQ:BLZE) had its underperform rating reaffirmed by analysts at William Blair.
BOX (NYSE:BOX) had its market perform rating reaffirmed by analysts at William Blair.
Braze (NASDAQ:BRZE) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a $43.00 target price on the stock.
Crown Castle (NYSE:CCI) had its equal weight rating reaffirmed by analysts at Wells Fargo & Company. They currently have a $85.00 target price on the stock, down from their previous target price of $90.00.
Northland Securities assumed coverage on shares of Climb Global Solutions (NASDAQ:CLMB). They issued an outperform rating and a $32.00 target price on the stock.
Coya Therapeutics (NASDAQ:COYA) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $18.00 price target on the stock.
Credo Technology Group (NASDAQ:CRDO) had its neutral rating reaffirmed by analysts at Rosenblatt Securities. They currently have a $125.00 price target on the stock.
CommVault Systems (NASDAQ:CVLT) had its market perform rating reissued by analysts at William Blair.
Dropbox (NASDAQ:DBX) had its underperform rating reaffirmed by analysts at William Blair.
DraftKings (NASDAQ:DKNG) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $35.00 target price on the stock.
William Blair started coverage on shares of Eupraxia Pharmaceuticals (NASDAQ:EPRX). William Blair issued an outperform rating on the stock.
D. Boral Capital began coverage on shares of Fatpipe Inc/UT (NASDAQ:FATN). They issued a buy rating and a $8.00 target price on the stock.
Gossamer Bio (NASDAQ:GOSS) had its neutral rating reissued by analysts at Cantor Fitzgerald.
Greenland Technologies (NASDAQ:GTEC) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
GitLab (NASDAQ:GTLB) had its underperform rating reissued by analysts at William Blair.
The Hackett Group (NASDAQ:HCKT) had its outperform rating reissued by analysts at Barrington Research. They currently have a $17.00 price target on the stock.
Arete Research started coverage on shares of Hut 8 (NASDAQ:HUT). Arete Research issued a buy rating and a $136.00 price target on the stock.
Hawkins (NASDAQ:HWKN) had its buy rating reiterated by analysts at BWS Financial. BWS Financial currently has a $200.00 target price on the stock.
ImmunityBio (NASDAQ:IBRX) had its buy rating reiterated by analysts at D. Boral Capital. They currently have a $23.00 price target on the stock.
ING Group (NYSE:ING) had its equal weight rating reissued by analysts at Morgan Stanley.
UBS Group AG started coverage on shares of Jasper Therapeutics (NASDAQ:JSPR). UBS Group AG issued a neutral rating on the stock.
Lexicon Pharmaceuticals (NASDAQ:LXRX) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $6.00 target price on the stock.
Macy’s (NYSE:M) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a hold rating.
Microchip Technology (NASDAQ:MCHP) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Mirum Pharmaceuticals (NASDAQ:MIRM) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $130.00 price target on the stock.
MediciNova (NASDAQ:MNOV) had its buy rating reaffirmed by analysts at Maxim Group. They currently have a $6.00 target price on the stock.
Mereo BioPharma Group (NASDAQ:MREO) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co..
UBS Group AG began coverage on shares of MTN Group (OTCMKTS:MTNOY). UBS Group AG issued a buy rating on the stock.
MaxCyte (NASDAQ:MXCT) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.
N-able (NYSE:NABL) had its underperform rating reaffirmed by analysts at William Blair.
National Grid Transco (NYSE:NGG) had its neutral rating reissued by analysts at The Goldman Sachs Group, Inc..
Nutanix (NASDAQ:NTNX) had its market perform rating reaffirmed by analysts at William Blair.
NVIDIA (NASDAQ:NVDA) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $300.00 price target on the stock.
NVIDIA (NASDAQ:NVDA) had its buy rating reissued by analysts at Rosenblatt Securities. The firm currently has a $325.00 target price on the stock.
News (NASDAQ:NWSA) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Nyxoah (NASDAQ:NYXH) had its overweight rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $11.00 price target on the stock.
Benchmark Co. started coverage on shares of Odysight.ai (NASDAQ:ODYS). The firm issued a speculative buy rating and a $10.00 price target on the stock.
Pacific Gas & Electric (NYSE:PCG) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a $19.00 target price on the stock, down from their previous target price of $20.00.
Reddit (NYSE:RDDT) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Benchmark Co. initiated coverage on shares of Red Rock Resorts (NASDAQ:RRR). The firm issued a buy rating and a $67.00 target price on the stock.
SailPoint (NASDAQ:SAIL) had its overweight rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $23.00 target price on the stock.
SCYNEXIS (NASDAQ:SCYX) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Selective Insurance Group (NASDAQ:SIGI) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $95.00 target price on the stock.
Solid Biosciences (NASDAQ:SLDB) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $20.00 target price on the stock.
Super Micro Computer (NASDAQ:SMCI) had its market perform rating reaffirmed by analysts at Northland Securities. They currently have a $22.00 price target on the stock.
SSE (OTCMKTS:SSEZY) had its neutral rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Thomson Reuters (NASDAQ:TRI) had its equal weight rating reaffirmed by analysts at Wells Fargo & Company. Wells Fargo & Company currently has a $95.00 price target on the stock, down from their previous price target of $120.00.
UBS Group AG initiated coverage on shares of Vodacom Group (OTCMKTS:VDMCY). UBS Group AG issued a neutral rating on the stock.
Viking Therapeutics (NASDAQ:VKTX) had its buy rating reissued by analysts at HC Wainwright. They currently have a $102.00 target price on the stock.
Varonis Systems (NASDAQ:VRNS) had its market perform rating reaffirmed by analysts at William Blair.
Arete Research started coverage on shares of TeraWulf (NASDAQ:WULF). They issued a buy rating and a $30.00 target price on the stock.
Solitario Resources (NYSEAMERICAN:XPL) (TSE:SLR) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $1.20 price target on the stock.
YSS (NYSE:YSS) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $36.00 price target on the stock.
Zimmer Biomet (NYSE:ZBH) had its neutral rating reaffirmed by analysts at BTIG Research.
Receive News & Ratings for Ahold NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ahold NV and related companies with MarketBeat.com's FREE daily email newsletter.
